BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06672523 updates: 1. completion date: 2026-04-20 → 2027-10-25 2. primary completion date: 2026-04-20 → 2027-10-25
Clinical trial NCT06672523 updates: 1. completion date: 2026-04-20 → 2027-10-25 2. primary completion date: 2026-04-20 → 2027-10-25
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical